000 01836 a2200541 4500
005 20250514180657.0
264 0 _c20040312
008 200403s 0 0 fre d
022 _a0181-5512
024 7 _a10.1016/s0181-5512(04)96089-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSillaire-Houtmann, I
245 0 0 _a[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
_h[electronic resource]
260 _bJournal francais d'ophtalmologie
_cJan 2004
300 _a34-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 0 4 _aBenzamides
650 0 4 _aChoroid Neoplasms
_xdiagnosis
650 0 4 _aCiliary Body
650 0 4 _aConjunctival Neoplasms
_xdiagnosis
650 0 4 _aDiagnosis, Differential
650 0 4 _aEye Neoplasms
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
650 0 4 _aLiver Neoplasms
_xdiagnostic imaging
650 0 4 _aMale
650 0 4 _aMelanoma
_xdiagnosis
650 0 4 _aOphthalmoscopy
650 0 4 _aPredictive Value of Tests
650 0 4 _aRadionuclide Imaging
650 0 4 _aRadiopharmaceuticals
650 0 4 _aSensitivity and Specificity
650 0 4 _aSkin Neoplasms
_xdiagnostic imaging
650 0 4 _aTomography, X-Ray Computed
650 0 4 _aUltrasonography
650 0 4 _aUveal Neoplasms
_xdiagnosis
700 1 _aBonafous, J
700 1 _aVeyre, A
700 1 _aMestas, D
700 1 _aD'Incan, M
700 1 _aMoins, N
700 1 _aKemeny, J-L
700 1 _aChossat, F
700 1 _aBacin, F
773 0 _tJournal francais d'ophtalmologie
_gvol. 27
_gno. 1
_gp. 34-9
856 4 0 _uhttps://doi.org/10.1016/s0181-5512(04)96089-5
_zAvailable from publisher's website
999 _c14690460
_d14690460